Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v6-FR | Version v5-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2026-02-24 | 2026-02-24 |
| Drug Identification Number | 00022780 | 00022780 |
| Brand name | DILANTIN | DILANTIN |
| Common or Proper name | PHENYTOIN SODIUM | PHENYTOIN SODIUM |
| Company Name | BGP PHARMA ULC | BGP PHARMA ULC |
| Ingredients | PHENYTOIN SODIUM | PHENYTOIN SODIUM |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 1x100BTL CA, 1x1000 BTL CA | 1x100BTL CA, 1x1000 BTL CA |
| Anatomical Therapeutical Chemical (ATC) code | N03AB | N03AB |
| Anatomical Therapeutical Chemical (ATC) description | ANTIEPILEPTICS | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2026-03-03 | 2026-03-03 |
| Actual start date | ||
| Estimated end date | 2026-04-14 | 2026-04-14 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |